cancer therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Global Liver Cancer Partnering 2012 to 2018By Current Partnering "...... 012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, in......" | 01-Oct-2018 | $1995 | |
Global Lung Cancer Partnering 2012 to 2018By Current Partnering "...... nd Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in partnering deals
- Top deals by value
- Deals list......" | 01-Oct-2018 | $1995 | |
Global Lymphoma Partnering 2012 to 2018By Current Partnering "...... rt provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, industry s......" | 01-Oct-2018 | $1995 | |
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018By GBI Research "...... ed in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products.
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas, a large gland s......" | 31-Aug-2018 | $3995 | |
Global Metastatic Cancer Treatment Market Forecast 2018-2026By Inkwood Research "...... ng a CAGR of 7.13%.
Market Insights
The global metastatic cancer treatment market is segmented on the basis of therapeutic indication and products. The therapeutic indications include breast cancer, prostate cancer, lung cancer,......" | 17-Aug-2018 | $2500 | |
Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell TherapyBy BCC Research "...... p>- Highlight the ongoing clinical and non-clinical advancements in the field of CAR T-cell therapy.
- Access the side effects, disadvantages and limitations of existing CAR T-cell technologies.
- Examine the current marketed drugs, i......" | 24-Jul-2018 | $2750 | |
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the MarketBy GBI Research "...... d lifestyles.
CRC is a leading cause of death worldwide, accounting for 0.77 million deaths in 2015. Over half of the incident cases of CRC are diagnosed in patients over the age of 50, and as the aged population is projected to grow, the pre......" | 01-Jul-2018 | $4995 | |
Pancreatic Cancer - Pipeline Review, H1 2018By Global Markets Direct "...... Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites......" | 22-Jun-2018 | $2500 | |
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018By Global Markets Direct "...... angiocarcinoma) (Oncology) pipeline landscape.
Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile duct. Symptoms include discomfort in the tummy area (abdomen), loss of appetite, high temperatures (fevers) and weigh......" | 22-Jun-2018 | $2000 | |
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018By Global Markets Direct "...... y) pipeline landscape.
Glioblastoma also known as glioblastoma multiforme is a fast-growing glioma that develops from star-shaped glial cells that support the health of the nerve cells within the brain. Symptoms include headaches, blurre......" | 22-Jun-2018 | $2500 | |
|